RNK05047

· Ranok Therapeutics (Hangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RNK05047, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) [Phase 1, Phase 2]

See pricing